Plasma, the pale yellow liquid that makes up about 55% of your blood, is one of the most versatile substances in modern medicine. It treats everything from severe burns and traumatic injuries to rare genetic disorders and autoimmune diseases. About 92% water, plasma carries proteins, antibodies, and clotting factors that can be separated and turned into dozens of life-saving therapies. The global plasma products market was valued at $35.8 billion in 2024 and is projected to nearly double by 2034, reflecting just how many medical uses depend on it.
What Plasma Actually Contains
Plasma’s medical value comes from its protein content, which makes up roughly 7% of its composition. The remaining 1% is a mix of hormones, vitamins, salts, and enzymes. The key proteins include albumin (which maintains blood volume and pressure), immunoglobulins (antibodies that fight infection), fibrinogen (essential for blood clotting), and a range of individual clotting factors. Each of these can be isolated and concentrated into specific treatments through a process called fractionation, which is why a single plasma donation can help multiple patients with very different conditions.
Emergency and Trauma Care
Plasma transfusions are a frontline treatment for people experiencing massive blood loss, severe burns, or shock. After a major burn, the body launches an intense inflammatory response that damages the lining of blood vessels, causing fluid to leak out of the bloodstream. This leads to dangerously low blood volume and a cascade of organ stress. Transfusing frozen plasma helps repair that vessel lining, restore blood pressure, and replace clotting factors that get consumed during the crisis.
Trauma patients who have lost large amounts of blood often receive plasma alongside red blood cells. Rather than giving whole blood, modern medicine separates blood into components so that each part goes where it’s needed most. One pint of donated whole blood can be split to help several different patients. Plasma is frozen within 24 hours of donation to preserve its clotting factors, then thawed and transfused when needed.
Treating Bleeding and Clotting Disorders
Some of plasma’s most critical uses involve people whose blood doesn’t clot properly. Hemophilia A, caused by a deficiency in clotting factor VIII, and hemophilia B, caused by a deficiency in factor IX, are both treated with concentrated clotting factors extracted from donated plasma. These concentrates are reliable enough for patients to use at home as part of regular treatment programs.
The list of treatable clotting disorders goes well beyond hemophilia. Plasma-derived concentrates exist for deficiencies in factors VII, XI, and XIII, as well as for von Willebrand disease and conditions involving multiple clotting factor deficiencies at once. For factor V deficiency, where no concentrate has been developed, whole plasma remains the only replacement option. Plasma products are also used to reverse the effects of blood-thinning medications when a patient needs emergency surgery or is bleeding uncontrollably.
Immune System Support
Immunoglobulin therapy, commonly called IVIG, is one of the highest-demand plasma-derived treatments. It works by pooling antibodies from thousands of donors into a single infusion, giving the recipient a broad defense against infections their own immune system can’t handle. Think of it as borrowing immune reinforcements from a crowd.
IVIG is used for people born with primary immune deficiencies, conditions where the body produces little or no antibodies on its own. This includes several rare genetic disorders where the immune system is severely compromised from birth. But its uses extend far beyond that. IVIG is a standard treatment for Guillain-Barré syndrome (a condition where the immune system attacks nerves, causing rapid-onset weakness), Kawasaki disease in children, and chronic inflammatory demyelinating polyneuropathy, a disorder that causes progressive weakness and impaired sensation in the legs and arms.
It’s also used to manage a range of autoimmune conditions where the immune system mistakenly attacks the body’s own tissues. These include lupus, myasthenia gravis (which causes severe muscle weakness), dermatomyositis (which affects skin and muscles), and stiff person syndrome. For patients undergoing bone marrow transplants or cancer treatments that suppress immunity, IVIG helps bridge the gap until their own immune system recovers.
Albumin for Liver Disease and Surgery
Albumin is the most abundant protein in plasma, and when extracted and concentrated, it serves as a critical treatment in hospital settings. Its primary job is pulling fluid back into blood vessels, which makes it especially useful when the body’s natural albumin levels drop dangerously low.
People with advanced liver disease are among the most common recipients. The liver produces albumin, so when it fails, fluid starts leaking into the abdomen. After draining that fluid (a procedure called paracentesis), doctors give albumin to prevent the circulatory system from collapsing. Albumin is also a standard part of care after liver, heart, and lung transplants, as well as during a blood-filtering procedure called plasmapheresis. In cardiac surgery patients, it’s used for volume replacement when standard fluids aren’t enough to stabilize blood pressure.
Treating Lung Disease From Genetic Deficiency
Alpha-1 antitrypsin deficiency is a genetic condition where the body doesn’t produce enough of a protein that protects the lungs from damage. Over time, this leads to emphysema, often at a younger age than typical. The treatment is straightforward: weekly infusions of alpha-1 antitrypsin protein purified from donor plasma, which helps slow further lung damage. This approach, called augmentation therapy, works best for people with the lowest protein levels. It does not, however, help with the liver disease that can also accompany this condition.
Passive Immunization Against Infections
Before vaccines build long-term immunity, plasma-derived antibody products can offer immediate, short-term protection. Specific immunoglobulin preparations exist for hepatitis A, hepatitis B, rabies, tetanus, and varicella (chickenpox), among others. These are given after a known or suspected exposure to buy the body time. For example, if someone is bitten by a potentially rabid animal, plasma-derived rabies immunoglobulin is administered alongside the vaccine to provide instant protection while the vaccine takes effect.
Where the World’s Plasma Comes From
Meeting global demand for plasma is a massive logistical challenge. Just five countries supply 80% of the world’s plasma: the United States, Austria, the Czech Republic, Germany, and Hungary. The U.S. alone provides about 70% of plasma used worldwide. One company, Grifols, operates roughly 400 collection centers globally and processes about a quarter of the total supply.
Unlike whole blood donation, plasma donation uses a process called plasmapheresis, where blood is drawn, the plasma is separated out, and the red blood cells are returned to the donor. This allows more frequent donation compared to whole blood. The process takes longer per visit, typically 60 to 90 minutes, but the body replenishes plasma faster than it replaces red blood cells. U.S. federal regulations govern how often donors can give, with specific frequency limits designed to protect donor health.
Demand continues to climb. The 8.5% annual growth rate of the plasma products market reflects expanding treatment options for autoimmune diseases, wider global access to clotting factor therapies, and aging populations that need more immune support. That growth puts ongoing pressure on collection systems to keep pace.